Simplex Trading’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Simplex Trading’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-627	Closed	-$27K	–	9889
2025 Q1	$27K	Buy	+627	New	+$27.7K	﹤0.01%	6346
2024 Q4	–	Sell	-39	Closed	-$1K	–	9791
2024 Q3	$1K	Buy	+39	New	+$1.67K	﹤0.01%	8309
2024 Q1	–	Sell	-910	Closed	-$37K	–	10068
2023 Q4	$37K	Buy	+910	New	+$34.5K	﹤0.01%	6382
2023 Q1	–	Sell	-10	Closed	–	–	10293
2022 Q4	$0	Buy	+10	New	+$416	﹤0.01%	10620
2021 Q4	–	Sell	-1,350	Closed	-$70K	–	11609
2021 Q3	$70K	Hold	1,350	–	–	﹤0.01%	7093
2021 Q2	$69K	Sell	1,350 -71	-5%	-$3.56K	﹤0.01%	7240
2021 Q1	$71K	Buy	1,421 +1,292	+1,002%	+$68.9K	﹤0.01%	6195
2020 Q4	$6K	Sell	129 -1,862	-94%	-$89K	﹤0.01%	7675
2020 Q3	$86K	Buy	1,991 +1,891	+1,891%	+$82.8K	﹤0.01%	5059
2020 Q2	$4K	Buy	100 +67	+203%	+$2.77K	﹤0.01%	7083
2020 Q1	$1K	Buy	+33	New	+$1.41K	﹤0.01%	7424
2019 Q1	–	Sell	-96	Closed	-$3K	–	7987
2018 Q4	$3K	Buy	+96	New	+$4.1K	﹤0.01%	6474
2017 Q1	–	Sell	-100	Closed	-$3K	–	6880
2016 Q4	$3K	Buy	+100	New	+$4.07K	﹤0.01%	4840

Other funds holding XPH

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Simplex Trading's XPH Position: Q2 2025 in Review

Simplex Trading sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2025, closing a stake of 627 shares — an estimated $27K sold.

Simplex Trading first reported a position in XPH in Q4 2016 and held it in 13 quarters. The position peaked at $86K in Q3 2020. 65 funds tracked by Wall St. Rank hold XPH as of Q2 2025.

Simplex Trading reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2025 after selling out during the quarter.
Simplex Trading sold 627 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2025, an estimated $27K.
Simplex Trading first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2016 and held it in 13 quarters.
Simplex Trading's State Street SPDR S&P Pharmaceuticals ETF position peaked at $86K in Q3 2020.
65 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.